COVID -19, Update, Thursday 11th June
Cases, 7,397,349
Deaths, 417,109
South Africa
Cases, 55,421
Deaths, 1,210
HIV
7.8 million HIV +
300,000 have TB
Western Cape Department of Health
13,000 cases, 435 deaths
HIV, 2.7 times more likely to die
2.58 for TB
1.41 for recovered TB
Irrespective of whether they are taking anti-AIDS drugs
Uncontrolled diabetes is 13 times more likely to die
Well-controlled diabetes, 4.65.
8% of coronavirus deaths could be linked to HIV
More work to disentangle the effects of obesity and poverty
Young demographic
United States
Arizona
Spike in cases due to reduced social distancing and not wearing masks
11 hospitals have full ICU
Lockdown lifted 15th May
7,000 new cases since 4th June
Weekly increase in;
Oregon
Nevada
Utah
New Mexico
Texas
Oklahoma
Arkansas
Missouri
Louisiana
Kentucky
Tennessee
North Carolina
South Carolina
Georgia
Florida
South Dakota
Michigan
Vermont
New Hampshire
Massachusetts
Burundi
Cases, 82
Deaths, 1
President Pierre Nkurunziza, aged 55, has died after suffering a cardiac arrest, the government says
Brazil
Population, 212 m
Cases, 772,416
Deaths, 39,680
Cities reopening
Deaths increasing
Spreading to all parts of the country
25% of population affected in some areas
Weak transportation system with crowding
No health minister
President wants all symptomatic cases to be prescribed hydroxychloroquine
Attempts to change data presentation
Cuba
Cases, 2,211
Deaths, 83
10 days with no deaths
Door to door checking for symptoms
Early detection, containment
Mandatory face masks
Under control
Russia
Cases, 501,800
Deaths, 6,522
Moscow
All self-isolation measures lifted
Life essentially returned to normal
Masks mandatory in public, but not well complied
China
31st December China notified WHO
Harvard Medical School research
Major Wuhan hospitals at points last autumn
Searches from the Wuhan region for information on ‘cough’ and ‘diarrhea’, spiked on Baidu
October
UK
Cases, 291,588
Deaths, 41,213
SAGE
9,400 new cases per day
Support bubble with one other household
Blood groups
A increased risk
O reduced risk
Vit D trial